Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software
What happened
The Food and Drug Administration (FDA) is classifying cardiovascular machine learning-based notification software into class II, meaning it will be subject to special controls. This action was signed by Donald Trump. The specific special controls applying to this device type are identified in this order and will be codified.
Why it matters
This classification aims to ensure the safety and effectiveness of these devices, while also making them more accessible to patients. The FDA believes this move will encourage innovation in medical technology by reducing regulatory burdens for beneficial devices.
Who it affects
- ›Patients needing cardiovascular devices
- ›Developers of cardiovascular machine learning software
- ›Healthcare providers using such software
- ›Medical device industry
The receipts are official. The summary is ours.
Read on Federal Register ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.